Author Index: R
• CURRENT TREATMENT FOR CHRONIC HEPATITIS B (CHB): A SYSTEMATIC REVIEW AND A NETWORK META-ANALYSIS
• IMPLEMENTATION AND ADOPTION OF THE TELEHOMECARE PROGRAM FOR PATIENTS WITH HEART FAILURE OR CHRONIC OBSTRUCTIVE PULMONARY DISEASE
• HEALTH UTILITIES IN MARGINALIZED CHRONIC HEPATITIS C PATIENTS PARTICIPATING IN A COMMUNITY-BASED HEPATITIS C PROGRAM
• IMPACT OF TELEHOMECARE PROGRAM ON MONITORING PARAMETERS AMONG COPD AND HF PATIENTS
• IMPACT OF TELEHOMECARE PROGRAM ON PATIENTS' QUALITY OF LIFE AND DISEASE-MANAGEMENT SKILLS
• NEW MODEL OF HEALTHCARE DELIVERY-TELEHOMECARE PROGRAM FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) AND HEART FAILURE (HF) PATIENTS IN ONTARIO, CANADA
• FACTORS AFFECTING THE DELIVERY OF A PHARMACIST-LED MEDICATION REVIEW. EVIDENCE FROM THE MEDSCHECK ANNUAL SERVICE IN ONTARIO
• IMPLEMENTATION AND ADOPTION OF THE TELEHOMECARE PROGRAM FOR PATIENTS WITH HEART FAILURE OR CHRONIC OBSTRUCTIVE PULMONARY DISEASE
• HEALTH UTILITIES IN MARGINALIZED CHRONIC HEPATITIS C PATIENTS PARTICIPATING IN A COMMUNITY-BASED HEPATITIS C PROGRAM
• IMPACT OF TELEHOMECARE PROGRAM ON MONITORING PARAMETERS AMONG COPD AND HF PATIENTS
• IMPACT OF TELEHOMECARE PROGRAM ON PATIENTS' QUALITY OF LIFE AND DISEASE-MANAGEMENT SKILLS
• NEW MODEL OF HEALTHCARE DELIVERY-TELEHOMECARE PROGRAM FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) AND HEART FAILURE (HF) PATIENTS IN ONTARIO, CANADA
• FACTORS AFFECTING THE DELIVERY OF A PHARMACIST-LED MEDICATION REVIEW. EVIDENCE FROM THE MEDSCHECK ANNUAL SERVICE IN ONTARIO
• VARIATION IN CAREGIVER PREFERENCES FOR PEDIATRIC ATTENTION-DEFICIT/HYPERACTIVITY DISORDER TREATMENTS: A COMPARISON OF STRATIFICATION AND LATENT CLASS ANALYSIS
• DO STAKEHOLDER PREFERENCES FOR ENGAGEMENT IN PEDIATRIC ATTENTION-DEFICIT/HYPERACTIVITY DISORDER TREATMENT CORRELATE WITH REPORTED OUTCOMES? A BEST WORST SCALING EXPERIMENT
• DO STAKEHOLDER PREFERENCES FOR ENGAGEMENT IN PEDIATRIC ATTENTION-DEFICIT/HYPERACTIVITY DISORDER TREATMENT CORRELATE WITH REPORTED OUTCOMES? A BEST WORST SCALING EXPERIMENT
• VARIATION IN CAREGIVER PREFERENCES FOR PEDIATRIC ATTENTION-DEFICIT/HYPERACTIVITY DISORDER TREATMENTS: A COMPARISON OF STRATIFICATION AND LATENT CLASS ANALYSIS
• IMPLEMENTING A MODEL OF ATTRIBUTE IDENTIFICATION USING CONTINUOUS STAKEHOLDER ENGAGEMENT TO PRIORITIZE TREATMENT DECISIONS FOR YOUTH WITH SERIOUS MENTAL AND COGNITIVE IMPAIRMENT
• DO STAKEHOLDER PREFERENCES FOR ENGAGEMENT IN PEDIATRIC ATTENTION-DEFICIT/HYPERACTIVITY DISORDER TREATMENT CORRELATE WITH REPORTED OUTCOMES? A BEST WORST SCALING EXPERIMENT
• IMPLEMENTING A MODEL OF ATTRIBUTE IDENTIFICATION USING CONTINUOUS STAKEHOLDER ENGAGEMENT TO PRIORITIZE TREATMENT DECISIONS FOR YOUTH WITH SERIOUS MENTAL AND COGNITIVE IMPAIRMENT
• DO STAKEHOLDER PREFERENCES FOR ENGAGEMENT IN PEDIATRIC ATTENTION-DEFICIT/HYPERACTIVITY DISORDER TREATMENT CORRELATE WITH REPORTED OUTCOMES? A BEST WORST SCALING EXPERIMENT